Såranalyse.dk ApS: Financial statements 2024
CVR: 32661971
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Såranalyse.dk ApS (CVR 32661971) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,513 and a net result of DKK -2,153 compared with DKK -3,093 the year before. Equity in the 2024 report amounted to DKK 224,657. The solvency ratio was 56.1%.
- Revenue
- DKK 0
- Gross Profit
- DKK -7,513
- Profit/Loss
- DKK -2,153
- Equity
- DKK 224,657
- Total Assets
- DKK 400,187
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -8 t. | -2 t. | 225 t. | - |
| 2023 | - | -8 t. | -3 t. | 227 t. | - |
| 2022 | 0 | -7 t. | -23 t. | 230 t. | - |
| 2021 | - | -7 t. | -11 t. | 253 t. | - |
| 2020 | - | -9 t. | -2 t. | 264 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Såranalyse.dk ApS has published its annual report for 2023. Gross profit came to DKK -8,309, and the net result was DKK -3,093.
About Såranalyse.dk ApS
Såranalyse.dk ApS was a Danish company of the type Anpartsselskab based in Ugerløse, founded in 2009. The company has been dissolved on 10 August 2026. The company was registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named SUSAN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,744 and a net result of DKK -297,616 compared with DKK -2,153 the year before. Equity in the 2025 report amounted to DKK -72,959.